Published in Oral Surg Oral Med Oral Pathol on March 01, 1986
Biomarkers of head and neck cancer, tools or a gordian knot? Int J Clin Exp Med (2015) 0.78
A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland. J Cancer Res Clin Oncol (2009) 0.76
The management of oral lichen planus. Oral Dis (1999) 1.68
Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol (2004) 1.62
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci U S A (1992) 1.56
Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol (2006) 1.50
Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis (2009) 1.44
Clinical features of microinvasive stage I oral carcinoma. Oral Dis (2010) 1.40
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol (2001) 1.20
Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy. Oral Dis (2003) 1.10
The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology (2007) 1.06
Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation (1993) 1.04
Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med (1998) 1.04
Periodontal status in oral mucous membrane pemphigoid: initial results of a case-control study. Oral Dis (2011) 1.03
Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci (1991) 1.02
The prevalence of oral mucosal lesions in adults from the Turin area. Oral Dis (2008) 1.01
Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology (1983) 0.98
Serological markers of HBV infectivity. Ann Ist Super Sanita (1987) 0.96
Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol (1994) 0.96
Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer (2001) 0.95
Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol (1993) 0.94
Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med (1996) 0.93
Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver (1994) 0.92
Localized oral amyloidosis of the palate. Amyloid (2006) 0.92
Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol (2001) 0.91
Endoscopic ultrasound-fine needle aspiration (EUS-FNA) for pancreatic lesions: effectiveness in clinical practice. Dig Liver Dis (2007) 0.90
Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. J Pharm Sci (1997) 0.89
[Erythema multiforme. A heterogeneous pathologic phenotype]. Minerva Stomatol (1999) 0.89
Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Tumori (2001) 0.89
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. Eur Urol (2000) 0.89
Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Mod Pathol (1994) 0.88
Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med (2003) 0.88
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors. Ann Oncol (2006) 0.88
Hepatitis C virus-associated oral lichen planus: no influence from hepatitis G virus co-infection. J Oral Pathol Med (2000) 0.87
Disappearance curves of tumor markers after radical surgery. Int J Biol Markers (1994) 0.87
Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay. J Med Virol (1994) 0.86
Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol (Dordr) (2011) 0.86
Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.86
Verrucous oral carcinoma: clinical findings and treatment outcomes in 74 patients in Northwest Italy. Minerva Stomatol (2008) 0.86
Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer. Breast Cancer Res Treat (2001) 0.86
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. Cancer Immunol Immunother (1998) 0.86
Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res (2001) 0.85
Detection of human androgen receptor mRNA in hepatocellular carcinoma by in situ hybridisation. Liver (1994) 0.85
Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity. J Oral Pathol Med (1999) 0.85
Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol (1998) 0.85
An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol (1997) 0.84
Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol (1987) 0.84
Hepatitis C virus-associated oral lichen planus: is the geographical heterogeneity related to HLA-DR6? J Oral Pathol Med (2005) 0.83
Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents. Eur J Cancer B Oral Oncol (1993) 0.83
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. Scand J Rheumatol (2014) 0.83
HCV genotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med (1997) 0.83
Comparative study of a bioresorbable and a non-resorbable membrane in the treatment of human buccal gingival recessions. J Periodontol (1996) 0.83
Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med (2003) 0.82
Effect of regular and decaffeinated coffee on serum gastrin levels. J Clin Gastroenterol (1986) 0.82
[Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300]. Minerva Med (2001) 0.82
Vinorelbine treatment of recurrent salivary gland carcinomas. Bull Cancer (1998) 0.82
A retrospective study of treatment of cerebral toxoplasmosis in AIDS patients with trimethoprim-sulphamethoxazole. J Infect (1998) 0.81
Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med (2008) 0.81
Hepatitis delta virus heterogeneity: a study by immunofluorescence. J Hepatol (1991) 0.81
[On-site evaluation and triage for endoscopic ultrasound-guided fine needle aspiration cytology. The Turin experience]. Minerva Med (2007) 0.81
[Usefulness of oral exfoliative cytology for the diagnosis of oral squamous dysplasia and carcinoma]. Minerva Stomatol (2004) 0.80
Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers. Digestion (1986) 0.80
Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws. J Oral Pathol Med (2011) 0.80
[An increase in gingival volume induced by drugs (phenytoin, cyclosporine and calcium antagonists). A review of the literature]. Minerva Stomatol (1998) 0.80
[Pemphigoid of the mucous membranes. The clinical, histopathological and immunological aspects and current therapeutic concepts]. Minerva Stomatol (1996) 0.79
[Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma]. Minerva Urol Nefrol (1990) 0.79
Oropharyngeal carcinoma during pregnancy: clinical and psycho-oncological aspects. Acta Otorhinolaryngol Ital (2003) 0.79
Phenotypic analysis of peripheral blood cell immunity in Italian patients with different varieties of oral lichen planus. Bull Group Int Rech Sci Stomatol Odontol (1996) 0.79
Diagnosis of deep-seated lymphomas by endoscopic ultrasound-guided fine needle aspiration combined with flow cytometry. Cytopathology (2011) 0.79
Staining reaction for beta-galactosidase in immunocytochemistry and in situ hybridization. Eur J Histochem (1992) 0.79
[Anti-erythrocyte antibodies with and without hemolysis in ulcerative colitis. Presentation of 2 cases]. Recenti Prog Med (1986) 0.79
Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: clinical applications of quantitative analysis. Clin Diagn Virol (1994) 0.78
Peri and intratumoral macrophage infiltration in laryngeal carcinoma. An immunohistochemical study. Acta Otolaryngol (1991) 0.78
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status. J Clin Pathol (2007) 0.78
Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions. Farmaco (2000) 0.78
[Quality of life after treatment in patients with laryngeal carcinoma]. Acta Otorhinolaryngol Ital (1997) 0.78
Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. Tumori (1989) 0.78
CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases. Am J Gastroenterol (1986) 0.78
Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis. Cancer (1990) 0.77
[A rare case of Merkel's tumor with intestinal metastases]. Ann Ital Chir (1991) 0.77
Duodenal lactoferrin in patients with chronic pancreatitis and gastrointestinal diseases. Digestion (1985) 0.77
HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol (2001) 0.77
Lack of association between hepatotropic transfusion transmitted virus infection and oral lichen planus in British and Italian populations. Br J Dermatol (2001) 0.77
Serum levels of Fas/Apo-1 and Bcl-2 in children with HIV-1 infection. Scand J Infect Dis (1998) 0.77
Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med (2001) 0.77
[Melanoma of the oral cavity. Review of the literature]. Minerva Stomatol (1997) 0.77
Serum and salivary CEA and GICA levels in oral cavity tumours. Int J Biol Markers (1989) 0.77
The monoclonal antibody-defined CAR-3 antigen is a serological marker associated with pancreatic carcinoma. Int J Biol Markers (1989) 0.77
Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection. Oral Oncol (2004) 0.77
Small cell carcinoma of the esophagus: a case report and review of the literature. Tumori (2000) 0.77
Tumor-associated trypsin inhibitor in pancreatic diseases. Scand J Clin Lab Invest Suppl (1991) 0.77
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Cancer Chemother Pharmacol (2009) 0.77
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol Suppl (1993) 0.77
Pathobiology of hepatitis delta virus infection at the cell level. Prog Clin Biol Res (1993) 0.77
Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity. Chemioterapia (1987) 0.77
In situ hybridization study of messenger RNA for estrogen receptor and immunohistochemical detection of estrogen and progesterone receptors in the human ovary. Gynecol Endocrinol (1996) 0.77
HIV/HCV co-infection: natural history. J Biol Regul Homeost Agents (2003) 0.76
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients. J Clin Lab Anal (2001) 0.76
p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Eur Urol (1997) 0.76